-
Sterilization remains the most popular form of contraception in the United States; 30.2% of couples rely on tubal sterilization for birth control, while 18.6% use oral contraceptives.1
-
Unrestricted access to emergency contraceptive pills (ECPs) remains blocked. The U.S. Department of Justice (DOJ) filed an appeal May 13, 2013, to delay the sale of ECPs to women of any age without a prescription.
-
The Centers for Disease Control and Prevention (CDC) now offers a free web-based self-study module, Genital Human Papillomavirus (HPV) Infection, as part of its Self-Study STD Modules for Clinicians series.
-
More than three years after new guidelines rejected routine annual mammograms for most women, women in all age groups continue to get yearly screenings, new research indicates.1
-
The National Institute of Allergy and Infectious Diseases (NIAID) is halting the administration of injections in the clinical trial of an investigational HIV vaccine regimen after a scheduled interim review data indicated the regimen did not prevent HIV infection, nor did it reduce viral load among vaccine recipients who became infected with HIV.
-
Five years after Australia launched a national human papillomavirus (HPV) vaccination program in young women, data indicates that genital wart cases have dropped not only among women, but heterosexual men as well.1
-
The U.S. Preventive Services Task Force (USPSTF) has just released its final recommendation statement on screening for HIV, and it recommends that clinicians screen all people ages 15 to 65, as well as younger adolescents and older adults who are at an increased risk for HIV infection, such as those who engage in unprotected vaginal or anal intercourse, use injection drugs, or are men who have sex with men.1
-
Colchicine, in addition to statins and other standard secondary prevention therapies, appeared effective for the prevention of cardiovascular events in patients with stable coronary disease.
-
As a federal program rolls out to award providers with incentives for achieving meaningful use in electronic health records, wide measure-by-measure variation can jeopardize the validity of electronic reporting.
-
On January 14, 2013, the FDA approved a device allowing detection of multiple gastrointestinal pathogens from a single sample of feces.1
